CN105709225A - 一种用于治疗高眼压的药物 - Google Patents

一种用于治疗高眼压的药物 Download PDF

Info

Publication number
CN105709225A
CN105709225A CN201410722048.3A CN201410722048A CN105709225A CN 105709225 A CN105709225 A CN 105709225A CN 201410722048 A CN201410722048 A CN 201410722048A CN 105709225 A CN105709225 A CN 105709225A
Authority
CN
China
Prior art keywords
intraocular pressure
pressure treatment
treatment drug
high intraocular
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410722048.3A
Other languages
English (en)
Inventor
刘和超
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Hongda Information Technology Co Ltd
Original Assignee
Shenyang Hongda Information Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Hongda Information Technology Co Ltd filed Critical Shenyang Hongda Information Technology Co Ltd
Priority to CN201410722048.3A priority Critical patent/CN105709225A/zh
Publication of CN105709225A publication Critical patent/CN105709225A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

一种用于治疗高眼压的药物。该药物包括:可乐定0.001mg,养眼成分1mg。本发明的优点:迅速降低眼压,养护眼睛。

Description

一种用于治疗高眼压的药物
技术领域:
本发明属于药品技术领域,特别涉及一种用于治疗高眼压的药物。
背景技术:
高眼压是种常见病,常见药物效果不好。
发明内容:
本发明针对现有技术的不足,提供一种用于治疗高眼压的药物。
该药物包括:可乐定0.001mg,养眼成分1mg。
本发明的优点:迅速降低眼压,养护眼睛。
具体实施方式:
本发明通过以下实施例进行说明:
该药物包括:可乐定0.001mg,养眼成分1mg。
本发明的优点:迅速降低眼压,养护眼睛。

Claims (1)

1.一种用于治疗高眼压的药物,其特征在于:该药物包括:可乐定0.001mg,养眼成分1mg。
CN201410722048.3A 2014-12-03 2014-12-03 一种用于治疗高眼压的药物 Pending CN105709225A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410722048.3A CN105709225A (zh) 2014-12-03 2014-12-03 一种用于治疗高眼压的药物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410722048.3A CN105709225A (zh) 2014-12-03 2014-12-03 一种用于治疗高眼压的药物

Publications (1)

Publication Number Publication Date
CN105709225A true CN105709225A (zh) 2016-06-29

Family

ID=56146469

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410722048.3A Pending CN105709225A (zh) 2014-12-03 2014-12-03 一种用于治疗高眼压的药物

Country Status (1)

Country Link
CN (1) CN105709225A (zh)

Similar Documents

Publication Publication Date Title
WO2016037154A8 (en) Recombinant hiv-1 envelope proteins and their use
MX2023003124A (es) Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
WO2015165413A8 (zh) 一种新型的稳定型抗体药物耦联物及其制备方法和用途
MX2016001023A (es) Formulaciones que contienen dapagliflozina amorfa.
MX2018014868A (es) Composiciones y metodos de uso de nintedanib para mejorar el exito de la cirugia del glaucoma.
WO2015123423A3 (en) Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
PH12016501357B1 (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
EP3513789A3 (en) Prophylactic and therapeutic agents for fgfr3 diseases
IN2013MU03583A (zh)
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
MX2017016368A (es) Farmaceuticos para tratamiento de infecciones virales de los ojos.
BR112014027676A2 (pt) formulação de cápsula solubilizada de [(1s)-1-{[(2s,4r)-4-(7-cloro-4metóxi-isoquinolin-1-ilóxi)-2-({(1r,2s)-1-[(ciclopropilsulfonil)carbamoil]-2-etenilciclopropil}carbamoil)pirrolidin-1-il]carbonil}-2,2-dimetilpropil]carbamato de 1,1-dimetiletila
MX355770B (es) Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico.
CA3010788A1 (en) Methods of administering vasopressors
WO2015048188A3 (en) Modified fibroblast growth factors for the treatment of ocular disorders
WO2013189606A3 (en) Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
MX2019005309A (es) Anticuerpos anti-bag3 en combinacion con inhibidores del punto de control inmunitario para uso terapeutico.
MX2022006770A (es) Dispersiones solidas de bendamustina e infusion continua.
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
CN105709225A (zh) 一种用于治疗高眼压的药物
CN105708864A (zh) 一种用于治疗眼疲劳的药物
WO2014165513A3 (en) Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof
MX2019004736A (es) Mini-tabletas de melatonina y metodos de fabricacion de las mismas.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160629